REGENXBIO Inc. (RGNX) Net Cash Provided by (Used in) Financing Activities USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
REGENXBIO Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2024.
  • REGENXBIO Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $121 M.
  • REGENXBIO Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$35 M, a 21.2% decline from 2022.
  • REGENXBIO Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$28.8 M, a 115% decline from 2021.
  • REGENXBIO Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $195 M, a 2.48% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $121 M +$130 M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2023 -$9.04 M -$2.2 M -32.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 -$6.83 M -$218 M -103% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q1 2021 $211 M +$209 M +7553% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 $2.76 M -$1.37 M -33.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $4.13 M -$39 K -0.94% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $4.17 M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.